US2002160377A1PendingUtilityA1
Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular RNA -protein fusion formation
Priority: Aug 17, 1998Filed: Jul 20, 2001Published: Oct 31, 2002
Est. expiryAug 17, 2018(expired)· nominal 20-yr term from priority
C12N 15/10C12N 15/1062C12N 15/1075C12N 15/1096
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are methods for removing the 3′-untranslated regions from cDNA or mRNA molecules, as well as methods for the use of such products for RNA-protein fusion formation.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A library of nucleic acid molecules, each molecule comprising an open reading frame and lacking the 3′-untranslated region normally associated with said open reading frame.
2 . The library of claim 1 , wherein said nucleic acid is RNA.
3 . The library of claim 2 , wherein said RNA is messenger RNA.
4 . The library of claim 2 , wherein said RNA is cellular RNA.
5 . The library of claim 4 , wherein said cellular RNA is derived from a eukaryotic organism.
6 . The library of claim 5 , wherein said cellular RNA is derived from a mammal.
7 . The library of claim 6 , wherein said mammal is a human.
8 . The library of claim 1 , wherein said nucleic acid is DNA.
9 . The library of claim 1 , wherein said library comprises at least 10 5 members.
10 . The library of claim 1 , wherein said nucleic acid molecules of said library also lack stop codons.
11 . A library of nucleic acid molecules produced by the steps of:
(a) providing a library of DNA molecules, each having an open reading frame and a 3′-untranslated region, each of said DNA molecules terminating at its 5′ end in an overhang and at its 3′ end in a blunt end; and (b) treating said library of DNA molecules first with a 3′→5′ exonuclease and then with a single-stranded nuclease under conditions that allow removal of the 3′-untranslated regions of said DNA molecules.
12 . A library of nucleic acid molecules produced by the steps of:
(a) translating a library of mRNA molecules in vitro in a translation reaction mixture lacking functional translation release factor activity, resulting in pausing of the translation reaction mixture ribosomes at the stop codons of said mRNA molecules; (b) adding, to said translation reaction mixture of step (a), reverse transcriptase and oligonucleotide primers which are complementary to the 3′-untranslated regions of said mRNA molecules at a site proximal to said stop codons, under conditions which allow the synthesis of strands of DNA that are complementary to said 3′-untranslated regions and terminate at sites proximal to said stop codons; and (c) removing the RNA portions of the RNA-DNA duplexes formed in step (b), thereby removing the 3′-untranslated regions of said mRNA molecules.
13 . The library of claim 12 , produced by the further steps of:
(d) ligating to each of the 3′ ends of the products of step (c) a linker comprising a Type IIS restriction site; (e) extending the products of step (d) to produce double-stranded DNA molecules; and (f) treating said double-stranded DNA molecules with a Type IIS restriction enzyme that recognizes said Type II restriction site to cleave said DNA molecules and remove said stop codons.
14 . A library of nucleic acid molecules produced by the steps of:
(a) providing a population of mRNA molecules; (b) synthesizing strands of DNA, each of which is complementary to one of said mRNA molecules, using a random primer mixture, said random primer mixture comprising primers, each having
(i) a 3′ region comprising a stop codon flanked by a random oligonucleotide located 3′, 5′, or both to said stop codon; and
(ii) a 5′ region comprising a Type IIS restriction site;
(c) ligating to the 3′ ends of the DNA products of step (b) an oligonucleotide tail; (d) amplifying the products of step (c) using
(i) a first primer which is complementary to said Type IIS restriction site-containing sequence; and
(ii) a second primer which is complementary to said oligonucleotide tail; and
(e) treating the products of step (d) with a Type IIS restriction enzyme that recognizes said Type IIS restriction site to cleave said products, thereby removing the 3′-untranslated regions and stop codons.
15 . The library of nucleic acid molecules of claim 14 , produced by the further steps of:
(f) ligating a sequence which encodes an affinity tag to the cleaved ends of the products of step (e); (g) transcribing the products of step (f); (h) ligating peptidyl acceptors to the 3′ ends of the RNA products of step (g); (i) translating said products of step (h) to produce a population of RNA-protein fusions; and (j) substantially isolating RNA-protein fusions which comprise said affinity tag, thereby obtaining a population of mRNA molecules lacking 3′-untranslated regions and stop codons.
16 . A library of nucleic acid molecules produced by the steps of:
(a) providing a population of mRNA molecules; (b) synthesizing strands of DNA, each of which is complementary to one of said mRNA molecules, using a random primer mixture, said random primer mixture comprising primers, each having (i) a 5′ region which lacks a stop codon in at least one reading frame and (ii) a random 3′ region; and (c) synthesizing strands of DNA complementary to said DNA strands of step (b), using a second random primer mixture.Join the waitlist — get patent alerts
Track US2002160377A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.